Detalles de la búsqueda
1.
Human anti-C1q autoantibodies bind specifically to solid-phase C1q and enhance phagocytosis but not complement activation.
Proc Natl Acad Sci U S A;
120(50): e2310666120, 2023 Dec 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38048459
2.
Differences in IgG autoantibody Fab glycosylation across autoimmune diseases.
J Allergy Clin Immunol;
151(6): 1646-1654, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36716825
3.
Does COVID-19 impact the prevalence of myositis specific antibodies in the Netherlands? A comparative nationwide study.
J Autoimmun;
139: 103081, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37393780
4.
Analytical validation of the Hevylite assays for M-protein quantification.
Clin Chem Lab Med;
56(7): 1169-1175, 2018 06 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-29397379
5.
Correction: C4b-binding protein and factor H compensate for the loss of membrane-bound complement inhibitors to protect apoptotic cells against excessive complement attack.
J Biol Chem;
295(27): 9263, 2020 Jul 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32620691
6.
Targeted complement inhibition using bispecific antibodies that bind local antigens and endogenous complement regulators.
Front Immunol;
15: 1288597, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38817607
7.
Subsets of human type 2 macrophages show differential capacity to produce reactive oxygen species.
Cell Immunol;
284(1-2): 1-8, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23916683
8.
Differential IL-13 production by small intestinal leukocytes in active coeliac disease versus refractory coeliac disease.
Mediators Inflamm;
2013: 939047, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23690672
9.
Induction of regulatory T cells by macrophages is dependent on production of reactive oxygen species.
Proc Natl Acad Sci U S A;
107(41): 17686-91, 2010 Oct 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-20861446
10.
Safety and pharmacodynamic efficacy of eculizumab in aneurysmal subarachnoid hemorrhage (CLASH): A phase 2a randomized clinical trial.
Eur Stroke J;
8(4): 1097-1106, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37606053
11.
C1-inhibitor treatment in patients with severe complement-mediated autoimmune hemolytic anemia.
Blood Adv;
7(13): 3128-3139, 2023 07 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36920779
12.
CD68-expressing cells can prime T cells and initiate autoimmune arthritis in the absence of reactive oxygen species.
Eur J Immunol;
41(2): 403-12, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21268010
13.
Ncf1-associated reduced oxidative burst promotes IL-33R+ T cell-mediated adjuvant-free arthritis in mice.
J Immunol;
183(2): 874-81, 2009 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19553535
14.
Circulating C1q levels in health and disease, more than just a biomarker.
Mol Immunol;
140: 206-216, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34735869
15.
Macrophages suppress T cell responses and arthritis development in mice by producing reactive oxygen species.
J Clin Invest;
117(10): 3020-8, 2007 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17909630
16.
Endothelial and Inflammation Biomarker Profiles at Diagnosis Reflecting Clinical Heterogeneity and Serving as a Prognostic Tool for Treatment Response in Two Independent Cohorts of Patients With Juvenile Dermatomyositis.
Arthritis Rheumatol;
72(7): 1214-1226, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32103637
17.
Expression and production of the SERPING1-encoded endogenous complement regulator C1-inhibitor in multiple cohorts of tuberculosis patients.
Mol Immunol;
120: 187-195, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32179338
18.
Handbook of experimental pharmacology "dendritic cells": the use of dexamethasone in the induction of tolerogenic DCs.
Handb Exp Pharmacol;
(188): 233-49, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19031029
19.
Complement production and regulation by dendritic cells: molecular switches between tolerance and immunity.
Mol Immunol;
45(16): 4064-72, 2008 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-18926283
20.
Generation and characterization of a novel anti-rat CD40L antibody with inhibitory activities in vitro and in vivo.
J Immunol Methods;
335(1-2): 46-52, 2008 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18384807